FORMULATION ASPECTS ON DERMATOLOGICAL PREPARATIONS AND TRANSDERMAL DRUG DELIVERY SYSTEMS

被引:0
|
作者
JUNGINGER, HE
机构
来源
ACTA PHARMACEUTICA NORDICA | 1992年 / 4卷 / 02期
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:117 / 117
页数:1
相关论文
共 50 条
  • [1] ADVERSE DERMATOLOGICAL REACTIONS TO TRANSDERMAL DRUG DELIVERY SYSTEMS
    HOGAN, DJ
    MAIBACH, HI
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 22 (05) : 811 - 814
  • [2] Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy
    Kang, Yunxiang
    Zhang, Sunxin
    Wang, Guoqi
    Yan, Ziwei
    Wu, Guyuan
    Tang, Lu
    Wang, Wei
    PHARMACEUTICS, 2024, 16 (11)
  • [4] ASPECTS OF TOLERANCE OF TRANSDERMAL SYSTEMS FROM A DERMATOLOGICAL VIEW
    ZESCH, A
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (11A): : 1497 - 1500
  • [5] Transdermal drug delivery - Clinical aspects
    Kalia, YN
    Merino, V
    Guy, RH
    DERMATOLOGIC CLINICS, 1998, 16 (02) : 289 - +
  • [6] Transdermal drug delivery: Vehicle design and formulation
    Pefile, S
    Smith, EW
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1997, 93 (04) : 147 - 150
  • [8] TRANSDERMAL DRUG DELIVERY SYSTEMS
    BHARGAVA, HN
    OZA, BJ
    ROJANASKUL, Y
    DRUG & COSMETIC INDUSTRY, 1984, 134 (01): : 52 - &
  • [9] TRANSDERMAL DRUG DELIVERY SYSTEMS
    NIEDNER, R
    HAUTARZT, 1988, 39 (12): : 761 - 766
  • [10] Formulation and Stability Aspects of Nanosized Solid Drug Delivery Systems
    Szabo, Peter
    Zelko, Romana
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (22) : 3148 - 3157